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Background: Adenoids are nasopharyngeal lymphoid tissue aggregates that hypertrophy
between the ages of 6–10 and then usually atrophy at the age of 16. Adenoid hypertrophy
happens between the ages of 6 and 10but is uncommon in adults where it is commonly
misdiagnosed and mistreated. This study is aimed at documenting the incidence of adenoid
hypertrophy in adult Saudi patients, along with its symptoms, causes and risk factors so as to
allow safer estimates of the disease and facilitate diagnoses in future cases.
Methods: It was a prospective study involving 100 adult patients > 20 years ago, attending
Otolaryngology clinic for the first time were taken and their medical history and nose, ear and
neck examination findings recorded. Following this, an F.O. scope and CT scans were
performed to assess the nasopharyngeal mass, its severity and nature, followed by surgery
and removal and subsequent histopathological assessment.
Results: Nasopharyngeal mass was found in 24% cases, all of which were male. Snoring
was the most common symptom followed by nasal discharge, nasal obstruction and postnasal drip (70.6%). Immuno-compromising conditions and allergies were associated comorbidities.
Conclusions: Adenoid hypertrophy is not uncommon in Saudi adults. Symptoms seem to be
consistent enough to allow for a good diagnosis if the physician is aware of them. Gender is a
risk factor for the disease as are immuno-compromising conditions and allergies.
Keywords: Adenoid hypertrophy, Saudi, adults, risk factors, symptoms

INTRODUCTION
The Adenoids, nasopharyngeal tonsils, are part of the
Waldeyer’s Ring system of lymphatic tissues and is
defined as a constellation of lymphatic tissue on the
postro-superior wall of the nasopharynx. [1] Adenoids
hypertrophy defined as enlargement in the size of the
adenoid tissue usually occurs during childhood,
between the age of 6–10. [2] This is followed by
physiological atrophy at the age of 16. [2]
Presence of lymphoid hyperplasia in the adult
nasopharynx, including the persistence of childhood
adenoids, is associated with chronic persistent
inflammation. [3] Regressed adenoidal tissue may reproliferate in response to chronic inflammatory
conditions, long standing infections and local irritants.
Individuals with a compromised immune system, such
as diabetics and HIV sufferers, are especially at risk of
suffering from Adenoid hypertrophy resurgence. [4]
Once inflamed, the adenoids may enlarge sufficiently to
entirely block airflow through the nasal passages. [5]
And even if the enlargement is not substantial enough
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to physically block the nose, it can obstruct airflow
sufficiently to induce primarily mouth breathing and
affect voice pitch and tone. [6]
Considering the inefficiency of current diagnosis
methods and the general discomfort a patient may
suffer from an untreated condition, we conducted this
study, aiming to document the incidence of adenoid
hypertrophy, its symptoms, causes and risk factors.
With this information at hand, we hope to provide
physicians with an insight into the condition and more
adequate means for diagnoses.

PATIENTS AND METHODS
It was a prospective study involving Adult patients > 20
years of age, attending the otolaryngology department
for their first visit were studied over a 2 years period as
nasopharyngeal mass below 20 years of age is of little or
no significance.(4) Those presenting a nasal obstruction
and undergoing an F.O. scope (for the first time) and CT
scan were included in the study. Clinical history was
taken and all F.O and CT scan findings were
documented so as to assess the presence or severity of
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the nasopharyngeal mass. These scans were followed by
surgery to remove the mass and a sample of which was
sent to a histopathology lab for tissue examination and
final diagnosis.
All demographic data, F.O. scope and CT scan findings
were analyzed with the help of Statistical Package for
Social Sciences (SPSS) version 17.0 by IBM Inc., (USA).
Continuous variables were represented as a mean ±
standard deviation (SD) and were tested via a Chi
Square test or Fisher’s exact test. A t-testwas used to test
independent variables.
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RESULTS
Of the 100 individuals, 24 (24%) cases were found to
have detectable nasopharyngeal mass, while the
remaining 76 had other nasopharyngeal conditions. Out
of these cases, most common histological diagnosis was
adenoid hypertrophy in 17 cases. Those suffering from
Adenoids had a mean age of 30.07 ± 12.43, which was
significantly different (p = 0.008) to those presenting
other conditions (39.21 ± 13.78) (Table 1).

Table 1 Comparison of mean age between study groups
Diagnosis

n

Mean

SD

SE of Mean

Adenoid

15*

30.07

12.43

3.21

Non-adenoid

83

41.63

15.62

1.72

Total

98*

39.21

13.78

1.58

P value

0.008

* 2 patients did not supply their age

Although the majority of sufferers were male, the
difference between male and female incidence was no
significant (p = 0.599) (Table 2).

Table 2 Gender distribution of patients
Diagnosis
Gender

Total

Adenoid

Non-adenoid

Males

11

47

58

Females

6

36

42

Total

17

83

100

Among patients with adenoid hypertrophy, snoring
was the most common complaint (94.1%), followed by
nasal discharge (76.5%), nasal obstruction (70.6%),
post-nasal drip (70.6%) (Table 3).
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P value

0.599

The most common co-morbidities in Adenoid
hypertrophy sufferers were diabetes mellitus (23.5%),
thyroid enlargement (11.8%) and bronchial asthma
(11.8%). All remaining co-morbidities had prevalence of
6% or less (Table 4).
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Table 3 Symptoms of adult patients with adenoids
Symptoms

Frequency

Percent

Snoring

16

94.12

Nasal discharge

13

76.47

Nasal obstruction

12

70.59

Post nasal drip

12

70.59

Headache/facial pain

10

58.82

Recurrent pharyngitis

06

35.29

Hearing deficit

04

23.53

Sneezing

03

17.47

Intranasal polyps

03

17.47

Deflected nasal septum

02

11.76

Anosmia

02

11.76

The most common co-morbidities in Adenoid
hypertrophy sufferers were diabetes mellitus (23.5%),
thyroid enlargement (11.8%) and bronchial asthma
(11.8%). All remaining co-morbidities had prevalence of
6% or less (Table 4).
Table 4 Co-morbid diseases among adult patients
with adenoids
Co-morbid diseases

Frequency

Percent

Diabetes mellitus

4

23.53

Hypertension

2

11.76

Bronchial asthma

2

11.76

Allergic rhinitis

1

5.88

Recurrent tonsillitis

1

5.88

Ischemic heart disease

1

5.88

Thyroid swelling

2

11.76

Hypothyroidism

1

5.88

Renal transplant

1

5.88

DISCUSSION
Adenoids are found in the nasopharynx as a part of the
lymphoid tissue system known as the Waldeyer ring
which is comprised primarily of B-cell tissue, with the B
lymphocytes constituting up to 60% of the cellular
makeup. [7] It is believed that the function of the
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adenoids is that of a mucosa-associated lymphoid tissue
(MALT), which works similarly to the intestinal
counterpart in that it secrets immune cells to fight off
infection from an exposed internal surface. [8] But, like
any tissue, the Adenoids can also experience their own
pathologies. Since the adenoid tissue involutes with age,
it further complicates the diagnosis via radiographic
interpretation of nasopharyngeal scans, [9] as
nasopharyngeal soft tissue thickening can be the result
of either an arrest in the involution of the adenoids or a
new growth secondary to reactive hyperplasia or a
neoplastic process. [10, 11]
The exact prevalence of adenoid hypertrophy in adults
is not very clear in the literature. Most case series that
deal with symptomatic adenoid hypertrophy are
reported in pediatric age patients, [12-14] with
only a few more recent reports including younger
adults. [11,15-18]
Our study showed that 17% of adult Saudi patients
were diagnosed with adenoid hypertrophy. In another
study from Arabian population by Hamdan et al., found
that mean age of adult patients was 26 years and 54% of
their patients were males. Findings of current study are
different from them. [1]
We also found there to be a slight biasing towards the
male gender. This was not unexpected as previous
studies have also documented this fact [1] and it can’t be
explained.
Concerning the ages, we found the mean age to be 32
for Adenoid hypertrophy sufferers. This is slightly
above the commonly reported age which is roughly 26
[1] but it is not significantly different to raise any
concerns.
Snoring was the most commonly reported symptom,
followed by nasal discharge, nasal obstruction and post
nasal drip, symptoms which are extensively
documented in medical literature. [1,2,14,16-18,20]
These findings are expected when considering the
disease is an obstructive mass in the airways and
therefore come as no surprise.
In our study sample, 17.4% of individuals had allergies
as well as adenoid hypertrophy, a result that supports
that there may be a link between the conditions.
Unfortunately, no swabs from the nasopharynx were
taken for Gram staining or culturing because of the fact
that in the start, the authors were not aware of its
significance for an academic purpose and also due to
lack of microbiological services and funds in this regard
which makes a limitation of current study.
Regarding concurrent conditions, none of our patients
had otitis media at the time of examination, 17.4% had
deflected nasal septum, and 11.8% had intranasal
polyps. These findings are in agreement with available
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literature [22] there were also a proportion of patients
exhibiting immune-compromised states such as diabetes
mellitus and post-renal transplant. The presence of
these is also not unexpected and is widely documented
in the literature. [25-28]
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CONCLUSIONS
Adenoid hypertrophy is common (17%) in adults
especially those between the age of 21-30 years and
having nasopharyngeal mass. Gender is not found as a
risk factor for the disease however immunocompromising conditions like diabetes, post-transplant
state, thyroid enlargement and hypothyroidism and
allergic diseases like bronchial asthma and allergic
rhinitis may have some risk association with adenoid
hypertrophy.
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